FELIX ORTEGA: Open Payments
NPI 1720348295 · PERTH AMBOY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 49 payments from 10 companies in 2025. Trend: 2023 $191 · 2024 $147 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $140 |
| Amgen Inc. | 10 | $135 |
| Lilly USA, LLC | 8 | $119 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Exact Sciences Corporation | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Hologic Sales and Service, LLC | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
Products named: Kerendia, MOUNJARO, Ozempic, OTEZLA, KRYSTEXXA, Cologuard Collection Kit, Wegovy, BREZTRI.
Industry payments across NJ — which companies pay providers there.
